Cells for Cells ha generado conocimiento de alto nivel, reflejado en las siguientes publicaciones científicas en revistas especializadas:

TítuloAutoresRevistaAño
1Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial)Jorge G. Bartolucci, Fernando J. Verdugo, Paz L. González, Ricardo E. Larrea, Ema Abarzúa, Carlos Goset, Pamela G. Rojo, Iván Palma, Rubén Lamich, Pablo A. Pedreros, Gloria Valdivia, Valentina M Lopez, Carolina Nazzal, Francisca Alcayaga, Jimena Cuenca, Matthew J Brobeck, Amit N Patel, Fernando E Figueroa, Maroun KhouryCirculation Research2017
2Mesenchymal stem cells and their immunosuppressive role in transplantation toleranceContreras-Kallens P, Terraza C, Oyarce K, Gajardo T, Campos-Mora M, Barroilhet MT, Álvarez C, Fuentes R, Figueroa F, Khoury M, Pino-Lagos K.Annals of the New York Academy of Sciences2017
3Artificial Mitochondria Transfer: Current Challenges, Advances, and Future ApplicationsAndrés Caicedo, Pedro Aponte, Francisco Cabrera, Carmen Hidalgo,Maroun KhouryStem Cells Int.2017
4Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies.Alcayaga-Miranda F, Cuenca J, Khoury M.Front Immunol.2017
5Layer-by-layer approach for a uniformed fabrication of a cell patterned vessel-like construct.Wilkens CA, Rivet CJ, Akentjew TL, Alverio J, Khoury M, Acevedo JP.Biofabrication2016
6Prostate tumor-induced angiogenesis is blocked by exosomes derived from menstrual stem cells through the inhibition of reactive oxygen species.Alcayaga-Miranda F, González PL, Lopez-Verrilli A, Varas-Godoy M, Aguila-Díaz C, Contreras L, Khoury M.Oncotarget.2016
7The immunosuppressive signature of menstrual blood mesenchymal stem cells entails opposite effects on experimental arthritis and graft versus host diseases.Luz-Crawford P, Torres MJ, Noël D, Fernaández A, Toupet K, Alcayaga-Miranda F, Tejedor G, Jorgensen C, Illanes SE, Figueroa FE, Djouad F, Khoury M.Stem Cells.2016
8Harnessing the Angiogenic Potential of Stem Cell-Derived Exosomes for Vascular Regeneration.Alcayaga-Miranda F, Varas-Godoy M, Khoury M.Stem Cells Int.2016
9PPARß/δ directs the therapeutic potential of mesenchymal stem cells in arthritisLuz-Crawford P, Ipseiz N, Espinosa-Carrasco G, Caicedo A, Tejedor G, Toupet K, Loriau J, Scholtysek C, Stoll C, Khoury M, Noël D, Jorgensen C, Krönke G, Djouad F.Ann Rheum Dis.2016
10Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth.Lopez-Verrilli MA, Caviedes A, Cabrera A, Sandoval S, Wyneken U, Khoury M.Neuroscience2016
11Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis.Alcayaga-Miranda F, Cuenca J, Martin A, Contreras L, Figueroa FE, Khoury M.Stem Cell Res Ther.2015
12Chorion Mesenchymal Stem Cells Show Superior Differentiation, Immunosuppressive, and Angiogenic Potentials in Comparison With Haploidentical Maternal Placental Cells.González PL, Carvajal C, Cuenca J, Alcayaga-Miranda F, Figueroa FE, Bartolucci J, Salazar-Aravena L, Khoury M.Stem Cells Transl Med.2015
13MicroRNA Profiling of B Cell Subsets from Systemic Lupus Erythematosus Patients Reveals Promising Novel Biomarkers.Duroux-Richard I, Cuenca J, Ponsolles C, Piñeiro AB, Gonzalez F, Roubert C, Areny R, Chea R, Pefaur J, Pers YM, Figueroa FE, Jorgensen C, Khoury M, Apparailly F.Int J Mol Sc.2i2015
14Long-term results of intracoronary transplantation of autologous bone marrow cells in dilated cardiomyopathy.Bartolucci J, Verdugo FJ, Carrion F, Abarzúa E, Goset C, Lamich R, Sanhueza P, Pedreros P, Nazzal C, Khoury M. Figueroa FE.Rev Med Chil.2015
15Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells.Alcayaga-Miranda F, Cuenca J, Luz-Crawford P, Aguila-Díaz C, Fernandez A, Figueroa FE, Khoury M.Stem Cell Res Ther.22015
16Stem cells for the treatment of cardiovascular diseases. An update.Bartolucci J, Verdugo FJ, Larrea R, Carrión F, Lamich R, Pedreros P, Delgado M, Sanhueza P, Khoury M, Figueroa FE.Rev Med Chil. 22015
17Innate immune system and preeclampsiaPerez-Sepulveda A, Torres MJ, Khoury M, Illanes SE.Front Immunol.2012
18The promising potential of menstrual stem cells for antenatal diagnosis and cell therapy.Khoury M, Alcayaga-Miranda F, Illanes SE, Figueroa FE.Front Immunol2014
19Novel approaches to lupus drug discovery using stem cell therapy. Role of mesenchymal-stem-cell-secreted factors.Figueroa FE, Cuenca Moreno J, La Cava AExpert Opin Drug Discov.2014
20Mesenchymal stem cell treatment for autoimmune diseases: a critical review.Figueroa FE, Carrión F, Villanueva S, Khoury M.Biol Res.2012
21Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.Luz-Crawford P, Noël D, Fernandez X, Khoury M, Figueroa F, Carrión F, Jorgensen C, Djouad F.PLoS One22012
22Mesenchymal stem cells in osteoarticular pediatric diseases: an update.Norambuena GA, Khoury M, Jorgensen C.Pediatr Res. 22012